References
1. Jeong, W. I., Jeong, D. H., Do, S. H., Kim, Y. K., Park, H. Y., Kwon, O. D., Kim, T. H., & Jeong, K. S. (2005). Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. The Journal of veterinary medical science, 67(3), 235–242. Oggioni, C., Cena, H., Wells, J.C.K., Lara, J., Cells-Morales, C., & Siervo, M. (2015). Association between worldwide dietary and lifestyle pattern with total cholesterol concentrations and DALYs for infectious diseases: An Ecological Analysis. Journal of Epidemiology and Global Health. 5 (4): 315-325. Zong, G., Li, Y., Wanders, A. J., Alssema, M., Zock, P. L., Willett, W. C., Hu, F. B., & Sun, Q. (2016). Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies. BMJ (Clinical research ed.), 355, i5796. Houston, M. (2018). The relationship of saturated fats and coronary heart disease: fa(c)t or fiction? A commentary. Therapeutic advances in cardiovascular disease, 12(2), 33–37. Buettner, R., Parhofer, K.G., Woenckhaus, M., Wrede, C.E., Kunz-Schughart, L.A., Schölmerich, J., Bollheimer, L.C (2006): Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology. 6 (3): 485-501. Gao, M.; Ma, Y.; Liu, D. (2015). High-Fat Diet-Induced Adiposity, Adipose Inflammation, Hepatic Steatosis and Hyperinsulinemia in Outbred CD-1 Mice. PLOS ONE. 10, e0119784. von Frankenberg, A. D., Marina, A., Song, X., Callahan, H. S., Kratz, M., & Utzschneider, K. M. (2017). A high-fat, high-saturated fat diet decreases insulin sensitivity without changing intra-abdominal fat in weight-stable overweight and obese adults. European journal of nutrition, 56(1), 431–443. Guo, Z., Ali, Q., Abaidullah, M., Gao, Z., Diao, X., Liu, B., Wang, Z., Zhu, X., Cui, Y., Li, D., & Shi, Y. (2022). High fat diet-induced hyperlipidemia and tissue steatosis in rabbits through modulating ileal microbiota. Applied microbiology and biotechnology, 106(21), 7187–7207. Bendsen, N. T., Christensen, R., Bartels, E. M., & Astrup, A. (2011). Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. European journal of clinical nutrition, 65(7), 773–783. Siervo, M., Lara, J., Chowdhury, S., Ashor, A., Oggioni, C., & Mathers, J. C. (2015). Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. The British journal of nutrition, 113(1), 1–15. Samadian, F., Dalili, N., & Jamalian, A. (2016). Lifestyle Modifications to Prevent and Control Hypertension. Iranian journal of kidney diseases, 10(5), 237–263. Ozemek, C., Laddu, D. R.., Arena, R., & Lavie, C. J. (2018). The role of diet for prevention and management of hypertension. Current opinion in cardiology, 33(4), 388–393. Ogan, P.M., Obia, O., & Apugo, U.I. (2022). Effect of hydo-ethanolic extract of Solanum aethiopicum fruit on the lipid profile of wistar rats. Global Scientific Journals. 10 (3): 2483- Obia, O., Ezekiel-Hart, H., Laz-Okenwa, J.O.A., Reuben, E., Dan-Jumbo, Dagbota & Wami- Amadi, C.F. (2024): The effect of hydro-methanolic seed extract of Azanza garckeana (goron tula) on lipid profile and oxidative stress markers of wistar rats. International Journal of Medical Evaluation and Physical Report. 8 (5): 83-89. Onyeabo, C., Achi, N. K., Ekeleme-Egedigwe, C. A., Ebere, C. U., & Okoro, C. K. (2017). Haematological and biochemical studies on Justicia carnea leaves extract in phenylhydrazine induced-anemia in albino rats. Acta scientiarum polonorum. Technologia alimentaria, 16(2), 217–230. Nji, A. A., Chrysanthus, N., & Monyongo, N. D. (2020). Effects of Justicia carnea Leave on Hematological Parameters in Albino Mice Carried Out in Mbingo Annex Hospital Laboratory in Bamenda, North West Region, Cameroon. Journal of Advances in Microbiology, 20(10), 43–50. Iwetan, B. B., Obianime, A. W., Ewhre, L. O. and Kweki, G. R. (2022) “The Antioxidant Modulating Properties of Justicia carnea Extract on Sheep Red Blood Cells Immunized Mice”, Journal of Pharmaceutical Research International, 34(43B), pp. 58–74. Boqué, N., Campión, J., Iglesia, R., Garza, A.L., Milagro, F.I., San Román, B., Banuelos, O.J., Martanez, A (2012). Screening of polyphenolic plant extracts for anti-obesity properties in Wistar rats. Journal of Science and Food Agriculture. 93:1226-1232. Lichtenstein A. H. (1990). Intestinal cholesterol metabolism. Annals of medicine, 22(1), 49– Lin, X., Racette, S. B., Ma, L., Wallendorf, M., & Ostlund, R. E., Jr (2017). Ezetimibe Increases Endogenous Cholesterol Excretion in Humans. Arteriosclerosis, thrombosis, and vascular biology, 37(5), 990–996. Grefhorst, A., Verkade, H. J., & Groen, A. K. (2019). The TICE Pathway: Mechanisms and Lipid-Lowering Therapies. Methodist DeBakey cardiovascular journal, 15(1), 70–76. Chen, L., Zhao, Z. W., Zeng, P. H., Zhou, Y. J., & Yin, W. J. (2022). Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell cycle (Georgetown, Tex.), 21(11), 1121–1139. Plösch, T., Kruit, J. K., Bloks, V. W., Huijkman, N. C., Havinga, R., Duchateau, G. S., Lin, Y., & Kuipers, F. (2006). Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. The Journal of nutrition, 136(8), 2135–2140. Kris-Etherton, P. M., Petersen, K., & Van Horn, L. (2018). Convincing evidence supports reducing saturated fat to decrease cardiovascular disease risk. BMJ nutrition, prevention & health, 1(1), 23–26. Arthur, N. C., MaryGisel, N. U., Obia, O., & Ogadinma, N. I. (2022). GC-MS Analyzed Phytochemicals and Justicia Carnea Remediation of Cadmium-Induced Oxidative Stress, Hyperglycaemia, and Hyperlipidaemia in Male Wistar Rats. Himalayan Journal of Applied Medical Sciences and Research. 3(1): 88-95. Ray, K. K., Troquay, R. P. T., Visseren, F. L. J., Leiter, L. A., Scott Wright, R., Vikarunnessa, S., Talloczy, Z., Zang, X., Maheux, P., Lesogor, A., & Landmesser, U. (2023). Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial. The lancet. Diabetes & endocrinology, 11(2), 109–119.
